Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma
- 1 December 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 336 (8728) , 1396-1399
- https://doi.org/10.1016/0140-6736(90)93099-b
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.Thorax, 1990
- The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisationPostgraduate Medical Journal, 1990
- PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDYThe Lancet, 1989
- Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.Thorax, 1989
- Hypokalaemia and other non‐bronchial effects of inhaled fenoterol and salbutamol: a placebo‐controlled dose‐response study in healthy volunteers.British Journal of Clinical Pharmacology, 1987
- A comparative double-blind study of the bronchodilator effects and side effects of inhaled fenoterol and terbutaline administered in equipotent dosesRespiratory Medicine, 1982
- Cardiopulmonary Effects of Fenoterol and Salbutamol AerosolsChest, 1980
- Association between asthma mortality and isoproterenol aerosols: A reviewPreventive Medicine, 1978
- RISE AND FALL OF ASTHMA MORTALITY IN ENGLAND AND WALES IN RELATION TO USE OF PRESSURISED AEROSOLSThe Lancet, 1969
- Observations on recent increase in mortality from asthma.BMJ, 1968